Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Long-Term Deferred Tax: 2010-2025

Historic Long-Term Deferred Tax for BIO-TECHNE (TECH) over the last 1 years, with Jun 2025 value amounting to $10.3 million.

  • BIO-TECHNE's Long-Term Deferred Tax was N/A to $10.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.3 million, marking a year-over-year change of. This contributed to the annual value of $10.3 million for FY2025, which is N/A change from last year.
  • Per BIO-TECHNE's latest filing, its Long-Term Deferred Tax stood at $10.3 million for Q2 2025, which was up 1,812.24% from $539,000 recorded in Q1 2011.
  • BIO-TECHNE's Long-Term Deferred Tax's 5-year high stood at $10.3 million during Q2 2025, with a 5-year trough of $10.3 million in Q2 2025.
  • For the 1-year period, BIO-TECHNE's Long-Term Deferred Tax averaged around $10.3 million, with its median value being $10.3 million (2025).